Telo Genomics Corp TDSGF

Primary Symbol: V.TELO

Telo Genomics Corp. is a Canada-based biotech company. The Company is focused on the development and commercialization of predictive technological products designed to personalize treatment plans for patients who have specific conditions. The Company, through its wholly owned subsidiary, Telo Genomics Holdings Corp., is developing diagnostic and prognostic products for diseases that display genomic instability. Its lead product, TeloView SMM, is a high-complexity molecular assay available for clinical use to provide information to physicians treating patients with Smoldering Multiple Myeloma. Through proprietary telomere-based analysis, TeloView SMM selects high-risk SMM patients who are likely to benefit from earlier treatment intervention while identifying the larger subset of low-risk SMM patients who have a more stable form of the disease and do not require immediate treatment. The TeloView SMM assay has a potential total addressable market of over 500,000 tests per year.

TSXV:TELO - Post by User

Telo Genomics Corp

<< Previous

Bullboard Posts

Next >>

Post by westdakotadaveon May 17, 2023 10:46am

167 Views

Post# 35452378

82% Accurate Blood Test

$TDSGF $TELO.V

82% Accurate Blood Test

SEE: European Hematology Association Abstract P975

https://library.ehaweb.org/eha/2023/eha2023-congress/386804/shaji.kumar.three-dimensional.telomere.profiling.predicts.risk.of.relapse.in.html?f=listing%3D0%2Abrowseby%3D8%2Asortby%3D1%2Ac_id%3D386804

<< Previous

Bullboard Posts

Next >>

The Market Online’s Weekly Cannabis Report – May 3, 2024